As of Feb 21, 2025, Novartis AG Intrinsic Value is $134.6. This suggests it may be undervalued by 23.1% compared to its current price of around $109.4.

What is Novartis AG DCF (discounted cash flow) valuation?

As of Feb 21, 2025, Novartis AG's Discounted Cash Flow (DCF) valuation estimates its share price at $150.3. This suggests it may be overvalued by 37.4% to its current price of around $109.4, using a discount rate of 6.8% and terminal growth rate of 3.0%.

Is Novartis AG overvalued or undervalued?

Novartis AG is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $134.6, compared to a market price of around $109.4. This suggests a potential undervaluation of 23.1%.